Product
FOLFORINOX
1 clinical trial
1 indication
Indication
Small Bowel AdenocarcinomaClinical trial
Randomized Phase II Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel AdenocarcinomaStatus: Recruiting, Estimated PCD: 2027-02-01